[Screening for alpha 1-antitrypsin deficiency in neonates]

Area of Science:

• Medical screening
• Biochemistry
• Pediatrics

Context:

• Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder.
• Early detection in children is crucial for managing associated health risks.
• Previous AATD screening studies have varied in methodology and population focus.

Purpose:

• To implement and evaluate a cost-effective screening method for AATD in a large pediatric cohort.
• To determine the incidence of AATD in the Czechoslovak population.
• To assess the feasibility of expanding AATD screening nationally.

Summary:

• A two-year screening of 113,274 children identified those with low alpha-1-antitrypsin levels (<1.5 g/l) for phenotype assessment.
• Quantitative assessment in 120 neonates confirmed physiological ranges (1.4-3.32 g/l).
• The study revealed a lower incidence of AATD in Czechoslovakia compared to international data.

Impact:

• Highlights the effectiveness of an economical screening approach for AATD.
• Provides crucial epidemiological data on AATD prevalence in a specific population.
• Informs discussions on the clinical, ethical, and economic viability of nationwide AATD screening programs.